A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2002
11/07/2002	WO2001048187A9 A molecular switch for regulating mammalian gene expression
11/07/2002	WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002	WO2001037881A9 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
11/07/2002	WO2001037859A3 Pharmaceutical compositions containing compounds which increase or decrease tmtnf levels
11/07/2002	WO2001021220A9 Bioprosthetic heart valves
11/07/2002	US20020166138 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/07/2002	US20020166136 Anti-inflammatory therapies using cytokine signaling regulated by a SOCS-3 promoter
11/07/2002	US20020166134 Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same
11/07/2002	US20020166132 System for regulating in vivo the expression of a transgene by conditional inhibition
11/07/2002	US20020166130 Expression of active human factor IX in mammary tissue of transgenic animals
11/07/2002	US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002	US20020165378 Human membrane antigen tm4 superfamily protein and dna encoding this protein
11/07/2002	US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002	US20020165371 Compositions and methods for the therapy and diagnosis of breast cancer
11/07/2002	US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002	US20020165353 Transport protein for use in human therapeutics and diagnostics
11/07/2002	US20020165195 Method of treating androgen-dependent disorders
11/07/2002	US20020165194 Method for selective inactivation of viral replication
11/07/2002	US20020165193 Compositions and methods of treating tumors
11/07/2002	US20020165192 Grafting bone marrow; using inositol polyphosphatase; antigen for blocking gene expression
11/07/2002	US20020165191 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
11/07/2002	US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same
11/07/2002	US20020165189 Oligoribonucleotides and ribonucleases for cleaving RNA
11/07/2002	US20020165188 Methods for inhibition of tumorigenic properties of melanoma cells
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165185 Novel Heparin-induced CCN-like molecules and uses therefor
11/07/2002	US20020165184 Forming a polymer in the presence of a biologically active drug for delivery to a cell; cationic polyamine compounds for conjugation with polyethylene glycol and complexing with nucleic acids
11/07/2002	US20020165183 Methods for genetic immunization
11/07/2002	US20020165179 Multifunctional nanodevice platform
11/07/2002	US20020165177 Modified factor VIII cDNA
11/07/2002	US20020165173 T-cell factor (TCF); constructs having multiple repeats of a TCF-binding element linked to a promoter and used to express genes encoding therapeutic proteins; drug screening for anticancer agents that suppress transcription
11/07/2002	US20020165172 Compositions and methods for treating intracellular diseases
11/07/2002	US20020165171 Delivery construct for antisense nucleic acids and methods of use
11/07/2002	US20020165154 Lipoprotein-regulating medicaments
11/07/2002	US20020165152 14089, a novel human trypsin serine protease and uses thereof
11/07/2002	US20020165127 Antidiabetic agents
11/07/2002	US20020164802 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
11/07/2002	US20020164801 Human and mammalian DNA replication origin consensus sequences
11/07/2002	US20020164800 Retroviral vector
11/07/2002	US20020164799 Expression vector coding proteins for use in the treatment of cancer
11/07/2002	US20020164791 Primitive neural stem cells and method for differentiation of stem cells to neural cells
11/07/2002	US20020164786 Novel telomerase
11/07/2002	US20020164783 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders
11/07/2002	US20020164782 Adenovirus vectors for gene therapy
11/07/2002	US20020164767 DNA encoding the human serine protease C-E
11/07/2002	US20020164758 Enzymatic polypeptide for use in the diagnosis and treatment of allergies, heart and respiratory disorders
11/07/2002	US20020164748 Enzymatic polypeptide for use in the treatment of inflammation, autoimmune and tissue rejection disorders
11/07/2002	US20020164734 Human pelota homolog
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164717 Suppression of endothelial cell proliferation; obtain cells, incubate with modulators, monitor adjustment in cell proliferation
11/07/2002	US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer
11/07/2002	US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002	US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002	US20020164693 TM4SF receptor polynucleotides, polypeptides, and antibodies
11/07/2002	US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002	US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002	US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002	US20020164615 Protein complex for use in the dianosis and treatment of nervous system disorders, alzheimer's and non-insulin dependent diabetes mellitus
11/07/2002	US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor
11/07/2002	US20020164359 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
11/07/2002	US20020164355 Test to detect antibodies; calibration
11/07/2002	US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002	US20020164313 Therapy for muscular dystrophy
11/07/2002	US20020164311 Prevention of organ rejection
11/07/2002	US20020164309 Cell culture of nervous system cells
11/07/2002	US20020164308 Embryonic stem cells and neural progenitor cells derived therefrom
11/07/2002	US20020164306 Concurrent administering with protein replacement therapy
11/07/2002	US20020164305 Integrin fusion protein; binding to antibodies
11/07/2002	US20020164304 Lung therapy
11/07/2002	US20020164303 Administering nucleic acids to muscle tissue
11/07/2002	DE10121255A1 Use of alpha 1-antichymotrypsin polypeptide or nucleic acids encoding the polypeptide, or of a cell expressing the polypeptide, or of antibody against the polypeptide, for diagnosing, treating or preventing poorly-healing wounds
11/07/2002	DE10121254A1 Functional assay on the activity of human MRP8/MRP14 heterodimer, for diagnosing and treating skin diseases, wounds or wound-healing disturbances with reduced quantity of the heterodimer, in particular a diabetic ulcer
11/07/2002	CA2454601A1 Microparticle protection of therapeutic agents
11/07/2002	CA2448607A1 Colloidal metal compositions and methods
11/07/2002	CA2445969A1 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins
11/07/2002	CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	CA2445593A1 Genetically modified yt cell line and use thereof
11/07/2002	CA2445524A1 Stent-based delivery of statins to prevent restenosis
11/07/2002	CA2445410A1 Ovary-specific genes and proteins
11/07/2002	CA2445310A1 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002	CA2445298A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	CA2445266A1 Foot and mouth disease virus vaccine
11/07/2002	CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/06/2002	EP1254961A1 Improvments in gene therapy using compositions comprising a polynucleotide and interleukin-10
11/06/2002	EP1254951A1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method
11/06/2002	EP1254896A1 Cationic amphiphiles, preparation and method for transfection
11/06/2002	EP1254663A1 Anti-virus agent
11/06/2002	EP1254657A2 Liposomes
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254267A1 Compositions and methods for the early diagnosis of ovarian cancer
11/06/2002	EP1254265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides
11/06/2002	EP1254259A1 Antisense modulation of pepck-cytosolic expression
11/06/2002	EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254253A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies

1 ... 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 ... 870